| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.02 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.02 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |